Rethinking cardiac monitoring in patients receiving trastuzumab-based HER2-directed therapies for breast cancer: a meta-analysis and cost-effectiveness analysis

ESMO Open · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles